Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7878)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2015 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nooredinvand HA, Connell DW, Asgheddi M, Abdullah M, O’Donoghue M, Campbell L, Wickremasinghe MI, Lalvani A, Kon OM, Khan SA. Viral hepatitis prevalence in patients with active and latent tuberculosis. World J Gastroenterol 2015; 21(29): 8920-8926 [PMID: 26269682 DOI: 10.3748/wjg.v21.i29.8920] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i29/8920.htm |
| Number | Citing Articles |
| 1 |
Miren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, Aida Ortega-Alonso, M. Isabel Lucena, Raúl J. Andrade. Drug induced liver injury: an update. Archives of Toxicology 2020; 94(10): 3381 doi: 10.1007/s00204-020-02885-1
|
| 2 |
Juan Espinosa-Pereiro, Samiksha Ghimire, Marieke G. G. Sturkenboom, Jan-Willem C. Alffenaar, Margarida Tavares, Sarita Aguirre, Arturo Battaglia, Gladys Molinas, Teresa Tórtola, Onno W. Akkerman, Adrian Sanchez-Montalva, Cecile Magis-Escurra. Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial. Pharmaceutics 2022; 15(1): 9 doi: 10.3390/pharmaceutics15010009
|
| 3 |
Anja Jørgensen, Karen Bjørn-Mortensen, Sidse Graff Jensen, Ellen Sloth Andersen, Pernille Ravn. Prevalence of hepatitis B and C at a major tuberculosis centre in Denmark. Infectious Diseases 2021; 53(3): 196 doi: 10.1080/23744235.2020.1865562
|
| 4 |
Eun Soo Kim. Inflammatory bowel disease is no longer a risk factor of viral hepatitis infection in Asia. Intestinal Research 2017; 15(1): 5 doi: 10.5217/ir.2017.15.1.5
|
| 5 |
Grace C Y Lui, Ngai-Sze Wong, Rity Y K Wong, Yee-Kit Tse, Vincent W S Wong, Chi-Chiu Leung, Henry L Y Chan, Grace L H Wong. Antiviral Therapy for Hepatitis B Prevents Liver Injury in Patients With Tuberculosis and Hepatitis B Coinfection. Clinical Infectious Diseases 2019; doi: 10.1093/cid/ciz241
|
| 6 |
Tume Christopher Bonglavnyuy. Sero-prevalence of Hepatitis B and C virus and High Risk of Hepatotoxicity among TB/HIV Positive and HIV Negative Population in Western Cameroon. Global Journal of Infectious Diseases and Clinical Research 2017; : 001 doi: 10.17352/2455-5363.000011
|
| 7 |
Birhanu Getie, Getnet Ayalew, Anteneh Amsalu, Getachew Ferede, Gizachew Yismaw, Belay Tessema. Seroprevalence and Associated Factors of Hepatitis B and C Virus Among Pulmonary Tuberculosis Patients Attending Health Facilities in Gondar Town, Northwest Ethiopia. Infection and Drug Resistance 2021; : 3599 doi: 10.2147/IDR.S327503
|
| 8 |
Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India. Intestinal Research 2017; 15(1): 97 doi: 10.5217/ir.2017.15.1.97
|
| 9 |
James Clark-Wright, Pollyanna Hudson, Conor McCloskey, Stuart Carroll. Burden of selected infectious diseases covered by UK childhood vaccinations: systematic literature review. Future Microbiology 2020; 15(17): 1679 doi: 10.2217/fmb-2020-0170
|
| 10 |
Jiangshan Lian, Ping Hu, Yingfeng Lu, Yueying Liu, Xiaoxiao Wang, Yimin Zhang, Hongyu Jia, Yida Yang. Prophylactic antiviral treatment reduces the incidence of liver failure among patients coinfected with Mycobacterium tuberculosis and hepatitis B virus. Virus Research 2019; 270: 197664 doi: 10.1016/j.virusres.2019.197664
|
| 11 |
Ryan Cooper, Stan Houston, Christine Hughes, James C. Johnston. Chapitre 10: Le traitement de la tuberculose active chez les populations particulières. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2023; 7(6): 436 doi: 10.1080/24745332.2023.2226009
|
| 12 |
Elizabeth Whittaker, Elisa López-Varela, Claire Broderick, James A. Seddon. Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children. Frontiers in Pediatrics 2019; 7 doi: 10.3389/fped.2019.00233
|
| 13 |
Alemu Gedefie, Abdurahaman Seid, Genet Molla Fenta, Mihret Tilahun, Agumas Shibabaw, Abdurrahman Ali. Hepatitis B and C virus infections and associated factors among HIV-positive and HIV-negative tuberculosis patients in public health facilities, Northeast Ethiopia: A comparative cross-sectional study. SAGE Open Medicine 2023; 11: 205031212311666 doi: 10.1177/20503121231166642
|
| 14 |
Ryan Cooper, Stan Houston, Christine Hughes, James C. Johnston. Chapter 10: Treatment of active tuberculosis in special populations. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022; 6(sup1): 149 doi: 10.1080/24745332.2022.2039500
|
| 15 |
Ricardo Jorge Dinis-Oliveira. Pharmacokinetics, toxicological and clinical aspects of ulipristal acetate: insights into the mechanisms implicated in the hepatic toxicity. Drug Metabolism Reviews 2021; 53(3): 375 doi: 10.1080/03602532.2021.1917599
|
| 16 |
Robert J. Wong, Ashley Hubbard, Laurie Bagley, Rita Shiau, Amit S. Chitnis. Estimating Prevalence of Hepatitis B Virus Coinfection Among Adults With Tuberculosis. Journal of Clinical Gastroenterology 2022; 56(7): 601 doi: 10.1097/MCG.0000000000001533
|
| 17 |
Debbie E. Malden, Robert J. Wong, Amit S. Chitnis, Theresa M. Im, Sara Y. Tartof. Screening Practices and Risk Factors for Co-Infection with Latent Tuberculosis and Hepatitis B Virus in an Integrated Healthcare System — California, 2008-2019. The American Journal of Medicine 2024; 137(3): 258 doi: 10.1016/j.amjmed.2023.10.031
|
| 18 |
Philip Sarges, Joshua M Steinberg, James H Lewis. Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature. Drug Safety 2016; 39(9): 801 doi: 10.1007/s40264-016-0427-8
|